Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.

Saved in:
Bibliographic Details
Title: Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Authors: Kruse CA; Department of Immunology, University of Colorado Health Sciences Center, Denver 80262, USA., Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ
Source: Cancer gene therapy [Cancer Gene Ther] 2000 Jan; Vol. 7 (1), pp. 118-27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0929-1903
DOI:10.1038/sj.cgt.7700097